MedSource Awarded $2.8 million Oncology Study

(Houston, Texas - January 2, 2007) MedSource, a Contract Research Organization (CRO) and leading provider of Phase I-IV clinical trials support, headquartered in Houston, TX with affiliate offices in Seattle, WA and Raleigh, NC, announced today it has been awarded a large late phase Oral Mucositis trial to be conducted in the United States.

MedSource is a premier Contract Research Organization dedicated to delivering on-time, reliable clinical trial management services. MedSource has been providing quality results in Phase I-IV studies since 1997 and has extensive experience in complex clinical trials, with a special focus on oncology related programs. They have quickly grown into one of the premier monitoring groups in North America and have been recognized as an Inc. 500 company.

"This trial is a perfect fit for us. Over the past 24 months we have steadily increased the quality and scope of our services and have recently added offices in Seattle and Raleigh. As a company, we feel this is an excellent opportunity to partner with our client and to help them succeed. Our team is both excited and honored to have the opportunity to meet the specific needs of our client on this new and exciting program", stated Eric Lund, President of MedSource. "Over the next few years we aim to aggressively increase our reach. It is our goal as an organization to continue to strongly emphasize quality, expertise and service. This is the cornerstone of our company and what we have built our reputation on."

With clinical trial monitors located throughout North America, Europe and Latin America, MedSource is able to quickly and effectively meet the clinical trial needs of their clients. The staff at MedSource comes from a broad background of clinical research experience and draws together for a unique combination of quality, flexibility, responsiveness and integrity.

MedSource's corporate office is located in Houston, TX. More information about MedSource can be found at medsource.com or by calling (281) 286-2003.

For more information about Medsource contact:
Scott Fitzsimmons
(281) 286-2003
sfitzsimmons@medsource.com

Blair Keel
(281) 286-2003
kbkeel@medsource.com


PLAY SUBMISSION FROM MEDSOURCE

View our
e-Brochure

 



01-02-07
MedSource Awarded $2.8 million Oncology Study

04-16-06
Scott Schliebner appointed V.P., Strategic Development at MedSource

01-12-05
Pamela Kennedy joins MedSource

09-21-04:
MedSource announces its new partnership with IC Research

9-06-02
Houston Business Journal profile:
MedSource Consulting performs clinical cancer treatment studies